Skip to main content
logo
Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
19.90
+0.05 (0.25%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Jade Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Market Capitalization
1,266710-
Market Cap Growth
417.54%--
Enterprise Value
806512-
Last Close Price
19.9015.43-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
PB Ratio
2.882.13-
P/TBV Ratio
2.882.13-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Debt / Equity Ratio
0.000.00-2.30
Net Debt / Equity Ratio
-1.04-1.01-0.82
Net Debt / EBITDA Ratio
2.792.95-
Net Debt / FCF Ratio
3.723.53-0.84
Quick Ratio
14.6120.335.78
Current Ratio
14.9321.095.81
Return on Equity (ROE)
--89.19%-
Return on Assets (ROA)
--33.59%-
Return on Capital Employed (ROCE)
-37.40%-34.10%-106.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Earnings Yield
-9.83%-17.95%-
FCF Yield
-9.76%-13.37%-
Buyback Yield / Dilution
--893.82%-
SEC Filings: 10-K · 10-Q